Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma

✍ Scribed by Noah C. Choi; Adrian R. Timothy; Sheldon D. Kaufman; Robert W. Carey; Alan C. Aisenberg

• Publisher: John Wiley and Sons
• Year: 1979
• Tongue: English
• Weight: 506 KB
• Volume: 43
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/1097-0142(197905)43:5<1636::aid-cncr2820430512>3.0.co;2-e

✦ Synopsis

Thirty-nine patients with advanced non-Hodgkin's lymphoma (38 patients with lymphocytic lymphoma and 1 patient with mixed lymphocytic and histiocytic lymphoma) were treated by fractionated low dose whole body irradiation (WBI) with a minimum follow-up of 8 months. Twenty-eight patients had no previous treatment and the other 11 patients were in relapse after previous chemotherapy or regional radiotherapy. There were 20 and 19 patients in stages 111 and IV groups, respectively. The majority of patients (31) had nodular histology; diffuse lym'phocytic lymphoma was present in 8 patients (Rappaport criteria) (9). Constitutional symptoms were present in 10 patients. Thirty-three (85%) attained complete remission (CR) with median duration of remission 24 months. Actuarial survival was 78% and 74% at 3 and 4 years. However, relapse free survival was 26% at 3 and 4 years. A prospective randomized trial to compare 10 vs. 15 rad per fraction of fractionated WBI schedules (the same total dose 150 rad) demonstrated no difference in response rate, response duration, and median nadir platelet or WBC counts between the two schedules. Supplement radiotherapy to bulky tumor site revented local recurrence, but did not influence survival or duration of remission. Major toxicity was thrombocytopenia with median nadir platelet counts 77,000/mm3 (1 1,000-170,000/mm3). Five of 6 patients with diffuse lymphocytic poorly differentiated lymphoma attained CR. However, their median survival was 30 months which is much shorter than that of nodular lymphoma. Constitutional symptoms and advanced stage (stage 1V) were associated with shorter duration of remission. Response of patients in relapse after WBI to subsequent chemotherapy f local radiotherapy was CR in 50% and PR in 40%. Fractionated whole body irradiation is an excellent systemic induction agent for advanced lymphocytic and mixed lymphoma.